🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Moderna, Inc.

MRNA Healthcare
$190.6 $-55.21 (-22.46%)
Market Cap: $76.09 B
Gurus Holding
5
Popularity Rank
#2057
% of Shares Held
0.13%
Net Activity (Q2 2026)
-$34.48 M

Guru Ownership Trend

Guru Analysis for Moderna, Inc. (MRNA)

Moderna, Inc. (MRNA), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $100.31 M.

Top institutional holders include Cliff Asness and Jefferies Group.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $34.48 M net outflow during the quarter.

Recent activity highlights Cliff Asness who dramatically increased their stake. Conversely, Ray Dalio reduced exposure by 84.6%.

Key Holders

Top 5 by Value

$33.55 M
$1.73 M
$807,236
$760,172

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$32.04 M
Total Buy Value
New Buys 2
Additions 2
-$66.52 M
Total Sell Value
Reductions 1
Sold Out 3

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
4
Net Buyers
4

FAQs for Moderna, Inc. (MRNA)

Major holders include Cliff Asness ($33.55 M), Jefferies Group ($1.73 M), Ray Dalio ($807,236). According to the latest reported data, 5 tracked investment managers collectively hold approximately 526,307 shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $34.48 M, with 4 managers increasing positions and 4 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 3 fully exited MRNA. The total reported sell value was $66.52 M.

Yes, 2 managers opened new positions in MRNA, and 2 increased their existing holdings. The total reported buy value was $32.04 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.01% Add 1150.5% 479,141 $33.55 M Q2 2026
0.01% Add 30.2% 24,729 $1.73 M Q2 2026
0.00% Reduce -84.6% 11,527 $807,236 Q2 2026
0.00% New Buy 10,854 $760,172 Q2 2026
0.00% New Buy 56 $3,903 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form